搜尋結果
BioNTech Cancer Drug Licensed From MediLink Faces FDA Delay
Bloomberg· 7 小時前The Food and Drug Administration delayed a breast- and lung-cancer trial of an experimental ...
Google-backed Tempus AI closes first day of trading up 9% in Nasdaq stock market debut
CNBC· 3 日前... shares at $37 apiece on Thursday, at the top of its initial $35 to $37 target< ... ...
5 Unexpected Wellness Experiences For Parents At Four Seasons Maui
Forbes· 15 小時前Topping the hotel bucket lists of many Hawaii-loving parents, Four Seasons Resort Maui at ...
Things You Should Know About Adenoviruses
Forbes· 6 日前Once perceived as mere pathogens, adenoviruses have transformed remarkably, becoming ...
The Best Skincare For Women Over 50, According To Dermatologists
Forbes· 6 日前A dermatologist-recommended skincare routine for your 50s includes products that help promote ...
China's quantity and quality of innovate drugs joins global lead
China Daily· 3 日前"Among them are CAR-T therapy and monoclonal antibodies that use novel biotechnologies, novel traditional ...
InnovationRx: Tarsus Pharmaceuticals Takes Aim At Disease-Causing Bugs
Forbes· 6 日前The disease can also cause damage to eyelashes and cause other allergic reactions. Despite its ...
The Best New Skincare Treatments, According To A Trio Of Experts
Forbes· 6 日前Just in time for summer, a new crop of buzzy, non-invasive, results-driven skincare treatments ...
Brain science start-up Neuroelectrics uses electricity and a headcap to reduce seizures in ...
CNBC· 4 日前High up in the hills of Barcelona, brain science start-up Neuroelectrics is developing ...
Teladoc Health BrandVoice: GLP-1 End Game: Should Deprescribing Be The Goal?
Forbes· 4 日前The early stages of any new, clinically impactful drug put pressure on benefit leaders. While ...